These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 12626556

  • 1. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y, Meng L, Busuttil RW, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 2003 Mar 15; 170(6):3024-8. PubMed ID: 12626556
    [Abstract] [Full Text] [Related]

  • 2. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY, Lee EN, Lee J, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Joh JW, Kim SJ.
    Exp Mol Med; 2006 Jun 30; 38(3):284-94. PubMed ID: 16819287
    [Abstract] [Full Text] [Related]

  • 3. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
    Zhai Y, Meng L, Gao F, Busuttil RW, Kupiec-Weglinski JW.
    J Immunol; 2002 Oct 15; 169(8):4667-73. PubMed ID: 12370407
    [Abstract] [Full Text] [Related]

  • 4. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients.
    Wu Z, Wang Y, Gao F, Shen X, Zhai Y, Kupiec-Weglinski JW.
    J Immunol; 2008 Jul 15; 181(2):1096-102. PubMed ID: 18606661
    [Abstract] [Full Text] [Related]

  • 5. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL.
    J Immunol; 2000 Jan 01; 164(1):512-21. PubMed ID: 10605049
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Critical role of OX40 in CD28 and CD154-independent rejection.
    Demirci G, Amanullah F, Kewalaramani R, Yagita H, Strom TB, Sayegh MH, Li XC.
    J Immunol; 2004 Feb 01; 172(3):1691-8. PubMed ID: 14734751
    [Abstract] [Full Text] [Related]

  • 11. Defective alloreactive CD8 T cell function and memory response in allograft recipients in the absence of CD4 help.
    Zhai Y, Wang Y, Wu Z, Kupiec-Weglinski JW.
    J Immunol; 2007 Oct 01; 179(7):4529-34. PubMed ID: 17878349
    [Abstract] [Full Text] [Related]

  • 12. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
    van Maurik A, Fazekas de St Groth B, Wood KJ, Jones ND.
    J Immunol; 2004 Feb 15; 172(4):2163-70. PubMed ID: 14764682
    [Abstract] [Full Text] [Related]

  • 13. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
    Thornley TB, Brehm MA, Markees TG, Shultz LD, Mordes JP, Welsh RM, Rossini AA, Greiner DL.
    J Immunol; 2006 Feb 01; 176(3):1561-70. PubMed ID: 16424185
    [Abstract] [Full Text] [Related]

  • 14. Alloreactive CD8 T-cell primed/memory responses and accelerated graft rejection in B-cell-deficient sensitized mice.
    Ji H, Shen XD, Gao F, Busuttil RW, Zhai Y, Kupiec-Weglinski JW.
    Transplantation; 2011 May 27; 91(10):1075-81. PubMed ID: 21427633
    [Abstract] [Full Text] [Related]

  • 15. CD4+ T regulatory cell induction and function in transplant recipients after CD154 blockade is TLR4 independent.
    Zhai Y, Meng L, Gao F, Wang Y, Busuttil RW, Kupiec-Weglinski JW.
    J Immunol; 2006 May 15; 176(10):5988-94. PubMed ID: 16670307
    [Abstract] [Full Text] [Related]

  • 16. CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells.
    Ferrer IR, Wagener ME, Song M, Ford ML.
    PLoS One; 2012 May 15; 7(7):e40559. PubMed ID: 22792369
    [Abstract] [Full Text] [Related]

  • 17. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.
    Chen Y, Heeger PS, Valujskikh A.
    J Immunol; 2004 May 01; 172(9):5456-66. PubMed ID: 15100287
    [Abstract] [Full Text] [Related]

  • 18. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
    Ito H, Kurtz J, Shaffer J, Sykes M.
    J Immunol; 2001 Mar 01; 166(5):2970-81. PubMed ID: 11207246
    [Abstract] [Full Text] [Related]

  • 19. The CD154-CD40 T cell costimulation pathway is required for host sensitization of CD8(+) T cells by skin grafts via direct antigen presentation.
    Zhai Y, Shen XD, Gao F, Coito AJ, Wasowska BA, Salama A, Schmitt I, Busuttil RW, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 2002 Aug 01; 169(3):1270-6. PubMed ID: 12133948
    [Abstract] [Full Text] [Related]

  • 20. CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection.
    Jones ND, Van Maurik A, Hara M, Spriewald BM, Witzke O, Morris PJ, Wood KJ.
    J Immunol; 2000 Jul 15; 165(2):1111-8. PubMed ID: 10878390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.